Blonder Tongue Financials
This page shows Blonder Tongue (BDRL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Blonder Tongue generated $18.1M in revenue in fiscal year 2022. This represents an increase of 15.0% from the prior year.
Blonder Tongue's EBITDA was -$2.0M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 28.7% from the prior year.
Blonder Tongue reported -$2.9M in net income in fiscal year 2022. This represents a decrease of 3576.2% from the prior year.
Blonder Tongue earned $-0.22 per diluted share (EPS) in fiscal year 2022. This represents a decrease of 1200.0% from the prior year.
Blonder Tongue held $79K in cash against $0 in long-term debt as of fiscal year 2022.
Blonder Tongue had 13,349 shares outstanding in fiscal year 2022. This represents an increase of 2.6% from the prior year.
Blonder Tongue's gross margin was 30.2% in fiscal year 2022, indicating the percentage of revenue retained after direct costs. This is down 7.0 percentage points from the prior year.
Blonder Tongue's operating margin was -11.8% in fiscal year 2022, reflecting core business profitability. This is up 7.0 percentage points from the prior year.
Blonder Tongue's net profit margin was -16.1% in fiscal year 2022, showing the share of revenue converted to profit. This is down 16.7 percentage points from the prior year.
Blonder Tongue invested $1.8M in research and development in fiscal year 2022. This represents a decrease of 31.4% from the prior year.
BDRL Income Statement
| Metric | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3M+0.3% | $5.3M+24.3% | $4.2M+26.7% | $3.3M-16.3% | $4.0M-4.3% | $4.2M-3.8% | $4.3M+33.4% | $3.3M |
| Cost of Revenue | -$9.4M-343.6% | $3.9M+21.4% | $3.2M+32.1% | $2.4M+133.2% | -$7.2M-370.5% | $2.7M-2.2% | $2.7M+46.5% | $1.9M |
| Gross Profit | $2.1M+46.0% | $1.4M+32.8% | $1.1M+12.9% | $939K-31.4% | $1.4M-8.7% | $1.5M-6.6% | $1.6M+15.9% | $1.4M |
| R&D Expenses | $357K-6.5% | $382K-23.3% | $498K-7.9% | $541K-19.4% | $671K+1.7% | $660K+5.9% | $623K-2.4% | $638K |
| SG&A Expenses | $895K-12.3% | $1.0M+2.7% | $993K+8.8% | $913K+10.9% | $823K-8.6% | $900K-6.7% | $965K-10.6% | $1.1M |
| Operating Income | N/A | -$475K+50.6% | -$962K | N/A | -$777K-10.5% | -$703K-13.9% | -$617K+28.5% | -$863K |
| Interest Expense | $236K+3.5% | $228K+18.8% | $192K+44.4% | $133K-1.5% | $135K+15.4% | $117K-12.7% | $134K+4.7% | $128K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $90K+112.8% | -$703K+39.0% | -$1.2M+0.1% | -$1.2M-24.5% | -$927K-361.2% | -$201K-112.4% | $1.6M+492.8% | -$414K |
| EPS (Diluted) | $0.01+120.0% | $-0.05+44.4% | $-0.090.0% | $-0.09-200.0% | $-0.03-50.0% | $-0.02-118.2% | $0.11+375.0% | $-0.04 |
BDRL Balance Sheet
| Metric | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.0M-1.8% | $15.3M+24.2% | $12.3M+6.6% | $11.5M-3.2% | $11.9M-1.8% | $12.1M+1.9% | $11.9M+7.1% | $11.1M |
| Current Assets | $8.0M-3.2% | $8.2M-4.1% | $8.6M+13.9% | $7.5M-1.8% | $7.7M+0.5% | $7.6M+7.4% | $7.1M+11.9% | $6.4M |
| Cash & Equivalents | $79K-52.7% | $167K-53.7% | $361K+228.2% | $110K-59.9% | $274K+1.1% | $271K-21.2% | $344K+514.3% | $56K |
| Inventory | $4.0M-4.6% | $4.2M-16.3% | $5.0M0.0% | $5.0M+2.3% | $4.9M+18.9% | $4.1M+8.1% | $3.8M-6.6% | $4.0M |
| Accounts Receivable | $3.4M+7.5% | $3.2M+28.3% | $2.5M+77.4% | $1.4M-21.5% | $1.8M-0.3% | $1.8M-2.7% | $1.8M+69.5% | $1.1M |
| Goodwill | $493K0.0% | $493K0.0% | $493K0.0% | $493K0.0% | $493K0.0% | $493K0.0% | $493K0.0% | $493K |
| Total Liabilities | $13.9M-2.9% | $14.3M+32.4% | $10.8M+18.7% | $9.1M+5.8% | $8.6M+3.0% | $8.4M-0.5% | $8.4M-12.5% | $9.6M |
| Current Liabilities | $8.2M-3.7% | $8.5M-2.6% | $8.7M+27.8% | $6.8M+12.2% | $6.1M+7.4% | $5.6M+2.3% | $5.5M+11.0% | $5.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.1M+14.6% | $937K-36.2% | $1.5M-39.1% | $2.4M-26.6% | $3.3M-12.5% | $3.8M+7.6% | $3.5M+131.9% | $1.5M |
| Retained Earnings | -$30.2M+0.3% | -$30.3M-2.4% | -$29.6M-4.1% | -$28.5M-4.2% | -$27.3M-3.5% | -$26.4M-0.8% | -$26.2M+5.8% | -$27.8M |
BDRL Cash Flow Statement
| Metric | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | $78K | N/A | N/A | N/A | $234K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | -$4K | N/A | N/A | N/A | -$36K |
| Financing Cash Flow | N/A | N/A | N/A | -$238K | N/A | N/A | N/A | -$211K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BDRL Financial Ratios
| Metric | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.0%+12.2pp | 26.8%+1.7pp | 25.0%-3.1pp | 28.1%-6.2pp | 34.3%-1.7pp | 35.9%-1.1pp | 37.0%-5.6pp | 42.6% |
| Operating Margin | N/A | -9.0%+13.7pp | -22.7% | N/A | -19.5%-2.6pp | -16.9%-2.6pp | -14.2%+12.3pp | -26.6% |
| Net Margin | 1.7%+15.1pp | -13.4%+13.9pp | -27.2%+7.3pp | -34.5%-11.3pp | -23.2%-18.4pp | -4.8%-42.3pp | 37.5%+50.2pp | -12.7% |
| Return on Equity | 8.4% | N/A | N/A | N/A | N/A | N/A | 46.6% | N/A |
| Return on Assets | 0.6%+5.2pp | -4.6%+4.8pp | -9.4%+0.6pp | -10.0%-2.2pp | -7.8%-6.1pp | -1.7%-15.3pp | 13.7%+17.4pp | -3.7% |
| Current Ratio | 0.980.0 | 0.97-0.0 | 0.99-0.1 | 1.11-0.2 | 1.27-0.1 | 1.35+0.1 | 1.29+0.0 | 1.28 |
| Debt-to-Equity | 12.97-2.3 | 15.31+7.9 | 7.38+3.6 | 3.78+1.2 | 2.63+0.4 | 2.23-0.2 | 2.41-4.0 | 6.39 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Financial Health Signals
Based on FY2022 annual data. Scores normalized against common benchmarks.
Financial strength trend (9 signals). 7-9 = strong, 0-3 = weak.
Operating cash flow vs net income. Above 1.0x = cash-backed earnings.
Operating income vs interest expense. Above 5x = safe, below 2x = risky.
Similar Companies
Frequently Asked Questions
What is Blonder Tongue's annual revenue?
Blonder Tongue (BDRL) reported $18.1M in total revenue for fiscal year 2022. This represents a 15.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Blonder Tongue's revenue growing?
Blonder Tongue (BDRL) revenue grew by 15% year-over-year, from $15.8M to $18.1M in fiscal year 2022.
Is Blonder Tongue profitable?
No, Blonder Tongue (BDRL) reported a net income of -$2.9M in fiscal year 2022, with a net profit margin of -16.1%.
What is Blonder Tongue's earnings per share (EPS)?
Blonder Tongue (BDRL) reported diluted earnings per share of $-0.22 for fiscal year 2022. This represents a -1200.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Blonder Tongue's EBITDA?
Blonder Tongue (BDRL) had EBITDA of -$2.0M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.
What is Blonder Tongue's gross margin?
Blonder Tongue (BDRL) had a gross margin of 30.2% in fiscal year 2022, indicating the percentage of revenue retained after direct costs of goods sold.
What is Blonder Tongue's operating margin?
Blonder Tongue (BDRL) had an operating margin of -11.8% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.
What is Blonder Tongue's net profit margin?
Blonder Tongue (BDRL) had a net profit margin of -16.1% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.
What is Blonder Tongue's operating cash flow?
Blonder Tongue (BDRL) generated -$1.4M in operating cash flow during fiscal year 2022, representing cash generated from core business activities.
What are Blonder Tongue's total assets?
Blonder Tongue (BDRL) had $15.0M in total assets as of fiscal year 2022, including both current and long-term assets.
How much does Blonder Tongue spend on research and development?
Blonder Tongue (BDRL) invested $1.8M in research and development during fiscal year 2022.
How many shares does Blonder Tongue have outstanding?
Blonder Tongue (BDRL) had 13,349 shares outstanding as of fiscal year 2022.
What is Blonder Tongue's current ratio?
Blonder Tongue (BDRL) had a current ratio of 0.98 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
What is Blonder Tongue's debt-to-equity ratio?
Blonder Tongue (BDRL) had a debt-to-equity ratio of 12.97 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Blonder Tongue's return on assets (ROA)?
Blonder Tongue (BDRL) had a return on assets of -19.5% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is Blonder Tongue's cash runway?
Based on fiscal year 2022 data, Blonder Tongue (BDRL) had $79K in cash against an annual operating cash burn of $1.4M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Blonder Tongue's Piotroski F-Score?
Blonder Tongue (BDRL) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals.
Are Blonder Tongue's earnings high quality?
Blonder Tongue (BDRL) has an earnings quality ratio of 0.47x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation.
Can Blonder Tongue cover its interest payments?
Blonder Tongue (BDRL) has an interest coverage ratio of -2.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline.
How financially healthy is Blonder Tongue?
Blonder Tongue (BDRL) scores 23 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks.